Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:Chapter 17:Unit 17.12.
doi: 10.1002/0471142905.hg1712s76.

Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry

Haoyue Zhang  1 , Sarah P Young, David S Millington
Affiliations

Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry

Haoyue Zhang et al. Curr Protoc Hum Genet. 2013.

Abstract

Mucopolysaccharidoses (MPSs) are complex lysosomal storage disorders that result in the accumulation of glycosaminoglycans (GAGs) in urine, blood, and tissues. Lysosomal enzymes responsible for GAG degradation are defective in MPSs. GAGs including chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS), and keratan sulfate (KS) are disease-specific biomarkers for MPSs. This unit describes a stable isotope dilution-tandem mass spectrometric method for quantifying CS, DS, and HS in urine samples. The GAGs are methanolyzed to uronic or iduronic acid-N-acetylhexosamine or iduronic acid-N-sulfo-glucosamine dimers and mixed with internal standards derived from deuteriomethanolysis of GAG standards. Specific dimers derived from HS, DS, and CS are separated by ultra-performance liquid chromatography (UPLC) and analyzed by electrospray ionization tandem mass spectrometry (MS/MS) using selected reaction monitoring for each targeted GAG product and its corresponding internal standard. This new GAG assay is useful for identifying patients with MPS types I, II, III, VI, and VII.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.
    Akyol MU, Alden TD, Amartino H, Ashworth J, Belani K, Berger KI, Borgo A, Braunlin E, Eto Y, Gold JI, Jester A, Jones SA, Karsli C, Mackenzie W, Marinho DR, McFadyen A, McGill J, Mitchell JJ, Muenzer J, Okuyama T, Orchard PJ, Stevens B, Thomas S, Walker R, Wynn R, Giugliani R, Harmatz P, Hendriksz C, Scarpa M; MPS Consensus Programme Steering Committee; MPS Consensus Programme Co-Chairs. Akyol MU, et al. Orphanet J Rare Dis. 2019 May 29;14(1):118. doi: 10.1186/s13023-019-1080-y. Orphanet J Rare Dis. 2019. PMID: 31142378 Free PMC article.
  • Detection of Glycosaminoglycans in Biological Specimens.
    Khan SA, Nidhi FNU, Amendum PC, Tomatsu S. Khan SA, et al. Methods Mol Biol. 2023;2619:3-24. doi: 10.1007/978-1-0716-2946-8_1. Methods Mol Biol. 2023. PMID: 36662458 Free PMC article.
  • Neonatal Mass Urine Screening Approach for Early Detection of Mucopolysaccharidoses by UPLC-MS/MS.
    Menkovic I, Marchand AS, Boutin M, Auray-Blais C. Menkovic I, et al. Diagnostics (Basel). 2019 Nov 18;9(4):195. doi: 10.3390/diagnostics9040195. Diagnostics (Basel). 2019. PMID: 31752121 Free PMC article.
  • Advances in glycosaminoglycan detection.
    Khan SA, Mason RW, Kobayashi H, Yamaguchi S, Tomatsu S. Khan SA, et al. Mol Genet Metab. 2020 Jun;130(2):101-109. doi: 10.1016/j.ymgme.2020.03.004. Epub 2020 Mar 27. Mol Genet Metab. 2020. PMID: 32247585 Free PMC article. Review.
  • High-Throughput Glycomic Methods.
    Trbojević-Akmačić I, Lageveen-Kammeijer GSM, Heijs B, Petrović T, Deriš H, Wuhrer M, Lauc G. Trbojević-Akmačić I, et al. Chem Rev. 2022 Oct 26;122(20):15865-15913. doi: 10.1021/acs.chemrev.1c01031. Epub 2022 Jul 7. Chem Rev. 2022. PMID: 35797639 Free PMC article. Review.
See all "Cited by" articles

MeSH terms

LinkOut - more resources